LabCorp 2009 Annual Report Download - page 65

Download and view the complete annual report

Please find page 65 of the 2009 LabCorp annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 66

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66

sults
Corporate Headquarters
358 South Main Street
Burlington, NC 27215
336-584-5171
Information Sources
Information about LabCorp is available from
the following Company sources:
Investor Relations Contact
Stephen Anderson
Director
Investor Relations
336-436-5274
Center for Molecular Biology and Pathology
800-533-0567
Center for Occupational Testing
800-833-3984
Center for Esoteric Testing
800-334-5161
Paternity/Identity
800-742-3944
LabCorp Drug Development Laboratory Services
888-244-4102
Web Site
www.LabCorp.com
Transfer Agent
American Stock Transfer & Trust Company
Shareholder Services
6201 Fifteenth Avenue
Brooklyn, NY 11219
800-937-5449
www.amstock.com
Independent Registered
Public Accounting Firm
PricewaterhouseCoopers LLP
800 Green Valley Road, Suite 500
Greensboro, NC 27408
Annual Meeting
The annual meeting of shareholders will be
held at 9.00 a.m. EDT on May 12, 2010 at
The Paramount Theater, 128 East Front Street,
Burlington, NC 27215.
Form 10-K
Copies of Form 10-K as fi led with the Securities
and Exchange Commission are available without
cost to shareholders by writing to:
Laboratory Corporation of America Holdings
Investor Relations Department
358 South Main Street
Burlington, NC 27215
Safe Harbor
Forward-looking statements in this annual report
are subject to change based on various
important factors, including without limitation,
competitive actions in the marketplace and
adverse actions of governmental and other third-
party payers. Actual results could differ materially
from those suggested by these forward-looking
statements. Further information on potential
factors which could affect the Company’s
fi nancial results is included in the Company’s
Form 10-K for the year ended December 31,
2009 and subsequent fi lings.
Common Stock
The Common Stock trades on the New York
Stock Exchange (“NYSE”) under the symbol “LH”.
The following table sets forth for the calendar
periods indicated the high and low sales prices
for the Common Stock reported on the NYSE
Composite Tape.
2009 High Low
First Quarter 65.90 53.25
Second Quarter 68.09 57.08
Third Quarter 71.29 62.06
Fourth Quarter 76.74 63.81
2008 High Low
First Quarter 80.77 70.46
Second Quarter 77.95 68.89
Third Quarter 78.29 65.00
Fourth Quarter 71.27 52.93
Corporate Governance,
Code of Business Conduct and Ethics
The Company’s Corporate Governance Guidelines,
the Charters of its Audit Committee, Compensation
Committee, Quality and Compliance Committee,
and Nominating and Corporate Governance
Committee as well as the Company’s Code of
Business Conduct and Ethics are available on
the Company’s Web Site at www.LabCorp.com.
You can also obtain a hard copy of these
documents, without charge, upon written request
to Stephen Anderson, Laboratory Corporation
of America Holdings, 358 South Main Street,
Burlington, NC 27215.
LABORATORY CORPORATION OF AMERICA
Shareholder and Company Information
LABORATORY CORPORATION OF AMERICA 63
Designed and produced by Corporate Reports Inc./Atlanta www.corporatereport.com